Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PRAX-628 by Praxis Precision Medicines for Epilepsy: Likelihood of Approval
PRAX-628 is under clinical development by Praxis Precision Medicines and currently in Phase II for Epilepsy. According to GlobalData, Phase...